Click for best price
Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, Share 2022
This report contains market size and forecasts of Receptor Tyrosine Protein Kinase Targeted Drugs in global, including the following market information:
Global top five Receptor Tyrosine Protein Kinase Targeted Drugs companies in 2021 (%)
The global Receptor Tyrosine Protein Kinase Targeted Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Afatinib Dimaleate Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Receptor Tyrosine Protein Kinase Targeted Drugs include Aslan Pharmaceuticals Pte Ltd, Boehringer Ingelheim GmbH, GamaMabs Pharma SA, Hanmi Pharmaceuticals Co Ltd, Jiangsu Kanion Pharmaceutical Co Ltd, Minerva Neurosciences Inc, Pfizer Inc, Puma Biotechnology Inc and Shanghai Fosun Pharmaceutical (Group) Co Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Receptor Tyrosine Protein Kinase Targeted Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment Percentages, by Type, 2021 (%)
- Afatinib Dimaleate
- Dacomitinib
- Neratinib
- Neucardin
- Others
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Cardiovascular
- Central Nervous System
- Others
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Receptor Tyrosine Protein Kinase Targeted Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Receptor Tyrosine Protein Kinase Targeted Drugs revenues share in global market, 2021 (%)
- Key companies Receptor Tyrosine Protein Kinase Targeted Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
- Key companies Receptor Tyrosine Protein Kinase Targeted Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Aslan Pharmaceuticals Pte Ltd
- Boehringer Ingelheim GmbH
- GamaMabs Pharma SA
- Hanmi Pharmaceuticals Co Ltd
- Jiangsu Kanion Pharmaceutical Co Ltd
- Minerva Neurosciences Inc
- Pfizer Inc
- Puma Biotechnology Inc
- Shanghai Fosun Pharmaceutical (Group) Co Ltd
- XuanZhu Pharma Co Ltd
- Zensun (Shanghai) Sci & Tech Co Ltd
Report Attributes |
Report Details |
Report Title |
Receptor Tyrosine Protein Kinase Targeted Drugs Market, Global Outlook and Forecast 2022-2028 |
Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year |
2021 |
Forecast Year |
2029 |
Number of Pages |
70 Pages |
Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Receptor Tyrosine Protein Kinase Targeted Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Overall Market Size
2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size: 2021 VS 2028
2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Receptor Tyrosine Protein Kinase Targeted Drugs Players in Global Market
3.2 Top Global Receptor Tyrosine Protein Kinase Targeted Drugs Companies Ranked by Revenue
3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Companies
3.4 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Companies
3.5 Global Receptor Tyrosine Protein Kinase Targeted Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Receptor Tyrosine Protein Kinase Targeted Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase Targeted Drugs Players in Global Market
3.8.1 List of Global Tier 1 Receptor Tyrosine Protein Kinase Targeted Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase Targeted Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Markets, 2021 & 2028
4.1.2 Afatinib Dimaleate
4.1.3 Dacomitinib
4.1.4 Neratinib
4.1.5 Neucardin
4.1.6 Others
4.2 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue & Forecasts
4.2.1 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2022
4.2.2 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2023-2028
4.2.3 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales & Forecasts
4.3.1 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2022
4.3.2 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2023-2028
4.3.3 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiovascular
5.1.4 Central Nervous System
5.1.5 Others
5.2 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue & Forecasts
5.2.1 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2022
5.2.2 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2023-2028
5.2.3 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales & Forecasts
5.3.1 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2022
5.3.2 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2023-2028
5.3.3 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2021 & 2028
6.2 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue & Forecasts
6.2.1 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2022
6.2.2 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2023-2028
6.2.3 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales & Forecasts
6.3.1 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2022
6.3.2 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2023-2028
6.3.3 By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2028
6.4.2 By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2028
6.4.3 US Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.4.4 Canada Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.4.5 Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2028
6.5.3 Germany Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5.4 France Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5.5 U.K. Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5.6 Italy Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5.7 Russia Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.5.9 Benelux Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2028
6.6.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.6.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.6.5 South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.6.7 India Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2028
6.7.2 By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2028
6.7.3 Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.7.4 Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales, 2017-2028
6.8.3 Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.8.4 Israel Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
6.8.6 UAE Receptor Tyrosine Protein Kinase Targeted Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Aslan Pharmaceuticals Pte Ltd
7.1.1 Aslan Pharmaceuticals Pte Ltd Corporate Summary
7.1.2 Aslan Pharmaceuticals Pte Ltd Business Overview
7.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.1.4 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Aslan Pharmaceuticals Pte Ltd Key News
7.2 Boehringer Ingelheim GmbH
7.2.1 Boehringer Ingelheim GmbH Corporate Summary
7.2.2 Boehringer Ingelheim GmbH Business Overview
7.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.2.4 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Boehringer Ingelheim GmbH Key News
7.3 GamaMabs Pharma SA
7.3.1 GamaMabs Pharma SA Corporate Summary
7.3.2 GamaMabs Pharma SA Business Overview
7.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.3.4 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.3.5 GamaMabs Pharma SA Key News
7.4 Hanmi Pharmaceuticals Co Ltd
7.4.1 Hanmi Pharmaceuticals Co Ltd Corporate Summary
7.4.2 Hanmi Pharmaceuticals Co Ltd Business Overview
7.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.4.4 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Hanmi Pharmaceuticals Co Ltd Key News
7.5 Jiangsu Kanion Pharmaceutical Co Ltd
7.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Corporate Summary
7.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Business Overview
7.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Key News
7.6 Minerva Neurosciences Inc
7.6.1 Minerva Neurosciences Inc Corporate Summary
7.6.2 Minerva Neurosciences Inc Business Overview
7.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.6.4 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Minerva Neurosciences Inc Key News
7.7 Pfizer Inc
7.7.1 Pfizer Inc Corporate Summary
7.7.2 Pfizer Inc Business Overview
7.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.7.4 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Inc Key News
7.8 Puma Biotechnology Inc
7.8.1 Puma Biotechnology Inc Corporate Summary
7.8.2 Puma Biotechnology Inc Business Overview
7.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.8.4 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Puma Biotechnology Inc Key News
7.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd
7.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporate Summary
7.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Business Overview
7.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Key News
7.10 XuanZhu Pharma Co Ltd
7.10.1 XuanZhu Pharma Co Ltd Corporate Summary
7.10.2 XuanZhu Pharma Co Ltd Business Overview
7.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.10.4 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.10.5 XuanZhu Pharma Co Ltd Key News
7.11 Zensun (Shanghai) Sci & Tech Co Ltd
7.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Corporate Summary
7.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Business Overview
7.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Major Product Offerings
7.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Key News
8 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, Analysis
8.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity, 2017-2028
8.2 Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Receptor Tyrosine Protein Kinase Targeted Drugs Supply Chain Analysis
10.1 Receptor Tyrosine Protein Kinase Targeted Drugs Industry Value Chain
10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Upstream Market
10.3 Receptor Tyrosine Protein Kinase Targeted Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Receptor Tyrosine Protein Kinase Targeted Drugs in Global Market
Table 2. Top Receptor Tyrosine Protein Kinase Targeted Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Type
Table 9. List of Global Tier 1 Receptor Tyrosine Protein Kinase Targeted Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Receptor Tyrosine Protein Kinase Targeted Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), 2017-2022
Table 15. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), 2017-2022
Table 20. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), 2017-2022
Table 25. By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), 2023-2028
Table 26. By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales, (K Pcs), 2023-2028
Table 46. Aslan Pharmaceuticals Pte Ltd Corporate Summary
Table 47. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 48. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Boehringer Ingelheim GmbH Corporate Summary
Table 50. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 51. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. GamaMabs Pharma SA Corporate Summary
Table 53. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 54. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Hanmi Pharmaceuticals Co Ltd Corporate Summary
Table 56. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 57. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Jiangsu Kanion Pharmaceutical Co Ltd Corporate Summary
Table 59. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 60. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Minerva Neurosciences Inc Corporate Summary
Table 62. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 63. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Pfizer Inc Corporate Summary
Table 65. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 66. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Puma Biotechnology Inc Corporate Summary
Table 68. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 69. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Shanghai Fosun Pharmaceutical (Group) Co Ltd Corporate Summary
Table 71. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 72. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. XuanZhu Pharma Co Ltd Corporate Summary
Table 74. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 75. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Zensun (Shanghai) Sci & Tech Co Ltd Corporate Summary
Table 77. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offerings
Table 78. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 80. Global Receptor Tyrosine Protein Kinase Targeted Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Receptor Tyrosine Protein Kinase Targeted Drugs Production by Region, 2017-2022 (K Pcs)
Table 82. Global Receptor Tyrosine Protein Kinase Targeted Drugs Production by Region, 2023-2028 (K Pcs)
Table 83. Receptor Tyrosine Protein Kinase Targeted Drugs Market Opportunities & Trends in Global Market
Table 84. Receptor Tyrosine Protein Kinase Targeted Drugs Market Drivers in Global Market
Table 85. Receptor Tyrosine Protein Kinase Targeted Drugs Market Restraints in Global Market
Table 86. Receptor Tyrosine Protein Kinase Targeted Drugs Raw Materials
Table 87. Receptor Tyrosine Protein Kinase Targeted Drugs Raw Materials Suppliers in Global Market
Table 88. Typical Receptor Tyrosine Protein Kinase Targeted Drugs Downstream
Table 89. Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Clients in Global Market
Table 90. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Type
Figure 2. Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Application
Figure 3. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Receptor Tyrosine Protein Kinase Targeted Drugs Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Receptor Tyrosine Protein Kinase Targeted Drugs Revenue in 2021
Figure 9. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Receptor Tyrosine Protein Kinase Targeted Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 19. US Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 24. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 33. China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Receptor Tyrosine Protein Kinase Targeted Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Receptor Tyrosine Protein Kinase Targeted Drugs Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Receptor Tyrosine Protein Kinase Targeted Drugs by Region, 2021 VS 2028
Figure 50. Receptor Tyrosine Protein Kinase Targeted Drugs Industry Value Chain
Figure 51. Marketing Channels